Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)

Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)

<p>In recent years, β-blockers such as metoprolol have been upgraded to first-line antihypertensive drugs. However, metoprolol demonstrates poor prognosis effects on diseases such as stroke. Further clinical application may expand the possibility of its related adverse reactions. Currently, th...

Full description

Saved in:
Bibliographic Details
Main Author: Yikuan Du (16324215) (author)
Other Authors: Mengting Zhang (753780) (author), Ziyi Luo (8058782) (author), Zhonghan Liang (20471606) (author), Weijian Liang (6816539) (author), Zhixing Chen (1303152) (author), Ruiyun Fan (20471609) (author), Yin Huang (179237) (author), Jiaqi Li (220961) (author), Mianda Hu (20393949) (author), Jiahui Li (646449) (author), Jinfeng Zhu (589893) (author), Weichui Zhang (16324227) (author), Yi Liu (36759) (author), Chun Yang (251691) (author)
Published: 2024
Subjects:
Biochemistry
Medicine
Genetics
Pharmacology
Biotechnology
Immunology
Science Policy
Infectious Diseases
Biological Sciences not elsewhere classified
Metoprolol
FDA Adverse Events Reporting System
adverse events
disproportionality analysis
pharmacovigilance
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items